• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Subsequent malignant neoplasms after hematopoietic cell transplantation.

作者信息

Socié Gerard, Baker K Scott, Bhatia Smita

机构信息

Hematology Transplantation, APHP Hospital Saint Louis and University Paris VII Denis Diderot, Paris, France.

出版信息

Biol Blood Marrow Transplant. 2012 Jan;18(1 Suppl):S139-50. doi: 10.1016/j.bbmt.2011.10.005.

DOI:10.1016/j.bbmt.2011.10.005
PMID:22226098
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3260455/
Abstract
摘要

相似文献

1
Subsequent malignant neoplasms after hematopoietic cell transplantation.造血细胞移植后的后续恶性肿瘤
Biol Blood Marrow Transplant. 2012 Jan;18(1 Suppl):S139-50. doi: 10.1016/j.bbmt.2011.10.005.
2
Second malignancies after allogeneic hematopoietic stem cell transplantation: new insight and current problems.异基因造血干细胞移植后的第二原发恶性肿瘤：新见解与当前问题
Blood Rev. 2002 Jun;16(2):135-46. doi: 10.1054/blre.2002.0010.
3
Myelodysplastic syndromes complicating hematopoietic stem cell transplantation.造血干细胞移植相关的骨髓增生异常综合征
Cancer Treat Res. 2001;108:169-84. doi: 10.1007/978-1-4615-1463-3_10.
4
Risk factors for therapy-related myelodysplastic syndrome and acute myeloid leukemia treated with allogeneic stem cell transplantation.接受异基因干细胞移植治疗的治疗相关骨髓增生异常综合征和急性髓系白血病的危险因素。
Haematologica. 2009 Apr;94(4):542-9. doi: 10.3324/haematol.2008.000927. Epub 2009 Mar 10.
5
[Secondary solid tumor and late mortality after allogeneic hematopoietic stem cell transplantation].[异基因造血干细胞移植后的继发性实体瘤与晚期死亡率]
Rinsho Ketsueki. 2014 Jul;55(7):785-8.
6
Fatal Kaposi sarcoma after allogeneic stem cell transplant.异基因干细胞移植后发生的致命性卡波西肉瘤。
Leuk Lymphoma. 2011 Dec;52(12):2402-4. doi: 10.3109/10428194.2011.593275. Epub 2011 Jul 12.
7
Second solid tumors: screening and management guidelines in long-term survivors after allogeneic stem cell transplantation.第二原发肿瘤：异基因造血干细胞移植后长期生存者的筛查和管理指南。
Semin Hematol. 2012 Jan;49(1):4-9. doi: 10.1053/j.seminhematol.2011.10.013.
8
Allogeneic hematopoietic stem cell transplantation: an option for long-term survival for patients with simultaneous appearance of myeloid and lymphatic malignancies.异基因造血干细胞移植：同时出现髓系和淋巴系恶性肿瘤患者长期生存的一种选择。
Acta Haematol. 2013;129(3):135-6. doi: 10.1159/000343422. Epub 2012 Nov 29.
9
A case report of secondary oral squamous cell carcinoma after allogeneic hematopoietic stem cell transplantation.异基因造血干细胞移植后发生继发性口腔鳞状细胞癌的病例报告。
Oral Oncol. 2020 Oct;109:104629. doi: 10.1016/j.oraloncology.2020.104629. Epub 2020 Mar 9.
10
Comparison of outcomes after allogeneic hematopoietic stem cell transplantation in patients with follicular lymphoma, diffuse large B-cell lymphoma associated with follicular lymphoma, or de novo diffuse large B-cell lymphoma.比较滤泡性淋巴瘤、滤泡性淋巴瘤相关弥漫性大 B 细胞淋巴瘤或原发性弥漫性大 B 细胞淋巴瘤患者接受异基因造血干细胞移植后的结局。
Am J Hematol. 2012 Aug;87(8):770-5. doi: 10.1002/ajh.23246. Epub 2012 May 28.

引用本文的文献

1
Exploring the aftermath of hematopoietic cell transplantation: 18-year insights into post-transplant neoplasms.探索造血细胞移植的后果：对移植后肿瘤的18年洞察
Front Oncol. 2025 Jul 22;15:1589755. doi: 10.3389/fonc.2025.1589755. eCollection 2025.
2
Clonal hematopoiesis and risk of nonmyeloid subsequent malignant neoplasms after autologous hematopoietic cell transplantation.自体造血细胞移植后克隆性造血与非髓系后续恶性肿瘤风险
J Natl Cancer Inst. 2025 Sep 1;117(9):1925-1933. doi: 10.1093/jnci/djaf181.
3
Assessment of Survivorship in Allogeneic Hematopoietic Stem Cell Transplantation.

本文引用的文献

1
Variants at 6q21 implicate PRDM1 in the etiology of therapy-induced second malignancies after Hodgkin's lymphoma.6q21 上的变异与霍奇金淋巴瘤治疗后诱导的第二恶性肿瘤的发病机制有关。
Nat Med. 2011 Jul 24;17(8):941-3. doi: 10.1038/nm.2407.
2
Long-term survival and late deaths after allogeneic hematopoietic cell transplantation.异基因造血细胞移植后的长期生存和晚期死亡。
J Clin Oncol. 2011 Jun 1;29(16):2230-9. doi: 10.1200/JCO.2010.33.7212. Epub 2011 Apr 4.
3
Factors associated with adherence to preventive care practices among hematopoietic cell transplantation survivors.
异基因造血干细胞移植中生存情况的评估
Methods Mol Biol. 2025;2907:91-125. doi: 10.1007/978-1-0716-4430-0_5.
4
Incidence and outcomes of subsequent malignancy after allogeneic hematopoietic stem cell transplantation in adult patients with severe aplastic anemia.成年重型再生障碍性贫血患者异基因造血干细胞移植后继发恶性肿瘤的发生率及转归
Blood Res. 2024 Dec 24;59(1):44. doi: 10.1007/s44313-024-00046-2.
5
Genotype and Associated Cancer Risk in Individuals With Telomere Biology Disorders.端粒生物学紊乱个体的基因型与相关癌症风险
JAMA Netw Open. 2024 Dec 2;7(12):e2450111. doi: 10.1001/jamanetworkopen.2024.50111.
6
International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023 update.国际移植和细胞治疗长期幸存者的筛查和预防建议：2023 年更新版。
Bone Marrow Transplant. 2024 Jun;59(6):717-741. doi: 10.1038/s41409-023-02190-2. Epub 2024 Feb 27.
7
International Recommendations for Screening and Preventative Practices for Long-Term Survivors of Transplantation and Cellular Therapy: A 2023 Update.国际移植和细胞治疗长期幸存者筛查和预防建议：2023 年更新版。
Transplant Cell Ther. 2024 Apr;30(4):349-385. doi: 10.1016/j.jtct.2023.12.001. Epub 2024 Feb 27.
8
Risk of Secondary Malignancies in Hematopoietic Stem Cell Transplantation Recipients: A Nationwide Population-Based Study in Taiwan.造血干细胞移植受者的继发性恶性肿瘤风险：台湾的一项全国性基于人群的研究。
Balkan Med J. 2023 Mar 8;40(2):131-138. doi: 10.4274/balkanmedj.galenos.2023.2022-10-56. Epub 2023 Feb 22.
9
Selection bias in follow-up studies of stem cell transplantation survivors: an experience within the Maastricht Observational study of late effects after Stem cell trAnsplantation (MOSA).随访研究中的选择偏倚：来自 Maastricht 干细胞移植后晚期效应观察研究（MOSA）的经验。
Ann Hematol. 2023 Mar;102(3):641-649. doi: 10.1007/s00277-022-05070-9. Epub 2022 Dec 31.
10
Linking the Center for International Blood and Marrow Transplant Research Registry to the California Cancer Registry and California Hospital Patient Discharge Data.将国际血液和骨髓移植研究中心注册处与加利福尼亚癌症登记处和加利福尼亚医院患者出院数据相链接。
Transplant Cell Ther. 2022 Dec;28(12):859.e1-859.e10. doi: 10.1016/j.jtct.2022.09.016. Epub 2022 Sep 27.
与造血干细胞移植存活者遵行预防保健实践相关的因素。
Biol Blood Marrow Transplant. 2011 Jul;17(7):995-1003. doi: 10.1016/j.bbmt.2010.10.023. Epub 2010 Dec 8.
4
Secondary solid cancers after allogeneic hematopoietic cell transplantation using busulfan-cyclophosphamide conditioning.异基因造血细胞移植后使用白消安-环磷酰胺预处理的继发实体瘤。
Blood. 2011 Jan 6;117(1):316-22. doi: 10.1182/blood-2010-07-294629. Epub 2010 Oct 6.
5
Life expectancy in patients surviving more than 5 years after hematopoietic cell transplantation.造血细胞移植后生存超过 5 年的患者的预期寿命。
J Clin Oncol. 2010 Feb 20;28(6):1011-6. doi: 10.1200/JCO.2009.25.6693. Epub 2010 Jan 11.
6
Allogeneic transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia.同种异体移植治疗相关性骨髓增生异常综合征和急性髓系白血病。
Blood. 2010 Mar 4;115(9):1850-7. doi: 10.1182/blood-2009-10-249128. Epub 2009 Dec 23.
7
Lymphoproliferative disorders and de novo malignancies in intestinal and multivisceral recipients: improved outcomes with new outlooks.肠和多脏器移植受者的淋巴增生性疾病和新发恶性肿瘤：新观点改善了结局。
Transplantation. 2009 Oct 15;88(7):926-34. doi: 10.1097/TP.0b013e3181b7509c.
8
Genome-wide association study to identify novel loci associated with therapy-related myeloid leukemia susceptibility.全基因组关联研究以鉴定与治疗相关的髓系白血病易感性相关的新基因座。
Blood. 2009 May 28;113(22):5575-82. doi: 10.1182/blood-2008-10-183244. Epub 2009 Mar 18.
9
Basal cell skin cancer after total-body irradiation and hematopoietic cell transplantation.全身照射和造血细胞移植后的基底细胞皮肤癌。
Radiat Res. 2009 Feb;171(2):155-63. doi: 10.1667/RR1469.1.
10
Risk factors for lymphoproliferative disorders after allogeneic hematopoietic cell transplantation.异基因造血细胞移植后淋巴增殖性疾病的危险因素。
Blood. 2009 May 14;113(20):4992-5001. doi: 10.1182/blood-2008-09-178046. Epub 2009 Mar 5.